Chul‐min Lee
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 13
- Liver Disease Diagnosis and Treatment 11
- Oncology 7
- Peptidase Inhibition and Analysis 2
- Colorectal Cancer Surgical Treatments 2
- Co-authors
- Mimi Kim (16 shared papers)Bo-Kyeong Kang (15 shared papers)Dae Won Jun (9 shared papers)Eileen L. Yoon (7 shared papers)Jung Yeon Kim (3 shared papers)Eun‐Hee Nah (3 shared papers)Sung‐Jig Lim (2 shared papers)Huiyul Park (4 shared papers)
- Journals
- Scientific Reports (5 papers)European Radiology (3 papers)Korean Journal of Radiology (3 papers)Hepatology Research (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- South KoreaUnited StatesTaiwan
In The Last Decade
Chul‐min Lee
45 papers receiving 528 citations
Peers
Comparison fields: 5 of 80
- Hepatology 88
- Epidemiology 165
- Endocrinology, Diabetes and Metabolism 58
- Oncology 73
- Cancer Research 27
Countries citing papers authored by Chul‐min Lee
This map shows the geographic impact of Chul‐min Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul‐min Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul‐min Lee more than expected).
Fields of papers citing papers by Chul‐min Lee
This network shows the impact of papers produced by Chul‐min Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul‐min Lee. The network helps show where Chul‐min Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Chul‐min Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2023 | 50 | |
| 3 | 2007 | 38 | |
| 4 | 2022 | 28 | |
| 5 | 2005 | 26 | |
| 6 | 2020 | 26 | |
| 7 | 2021 | 21 | |
| 8 | 2022 | 21 | |
| 9 | 2021 | 20 | |
| 10 | 2016 | 20 | |
| 11 | 2021 | 17 | |
| 12 | 2022 | 17 | |
| 13 | 2016 | 17 | |
| 14 | 2012 | 16 | |
| 15 | 2016 | 15 | |
| 16 | 2004 | 14 | |
| 17 | 2020 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2024 | 9 | |
| 20 | 2021 | 9 |
About Chul‐min Lee
Chul‐min Lee is a scholar working on Epidemiology, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Surgery, having authored 49 papers that have together received 536 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (4 papers), Nutrition and Health in Aging (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Prostate Cancer Treatment and Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Colorectal Cancer Surgical Treatments (2 papers) and Esophageal and GI Pathology (2 papers). The work is most often cited by research in Hepatology (88 citations), Epidemiology (165 citations), Endocrinology, Diabetes and Metabolism (58 citations), Oncology (73 citations) and Cancer Research (27 citations). Chul‐min Lee has collaborated with scholars based in South Korea, United States and Taiwan. Frequent co-authors include Mimi Kim, Bo-Kyeong Kang, Dae Won Jun, Eileen L. Yoon, Jung Yeon Kim, Eun‐Hee Nah, Sung‐Jig Lim, Huiyul Park, So Jung Lee and Bo‐Kyeong Kang. Their work appears in journals such as Scientific Reports, European Radiology, Korean Journal of Radiology, Hepatology Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.